Breast Cancer Liquid Biopsy Market Report

China Breast Cancer Liquid Biopsy Industry Market Research Report 2023-2029

  • POSTDATE：Sep 14, 2023
  • PAGES：169
  • REPORT CODE：GMM1796974
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.

    This report elaborates on the current development of the Breast Cancer Liquid Biopsy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Illumina

    • Bio-Rad Laboratories

    • QIAGEN

    • Menarini Silicon Biosystems

    • Genomic Health

    • Biocept

    • Trovagene

    • Guardant Health

    • Myriad Genetics

    • RainDance Technologies

    • Roche Diagnostics

    By Type:

    • Circulating Tumor Cells (CTCs)

    • Other Circulating Biomarkers

    • Extracellular Vesicles (EVs)

    • Cell-Free DNA (CfDNA)

    By Application:

    • Hospitals

    • Laboratories

    • Diagnostic Centers

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Breast Cancer Liquid Biopsy Market Overview 2018-2029

    • 1.1 China Breast Cancer Liquid Biopsy Industry Development Overview

    • 1.2 China Breast Cancer Liquid Biopsy Industry Development History

    • 1.3 China Breast Cancer Liquid Biopsy Industry Market Size (2018-2029)

    • 1.4 China Breast Cancer Liquid Biopsy Market Analysis by Type from Production Side

      • 1.4.1 China Breast Cancer Liquid Biopsy Production Volume, Production Value and Growth Rate of Circulating Tumor Cells (CTCs) (2018-2029)

      • 1.4.2 China Breast Cancer Liquid Biopsy Production Volume, Production Value and Growth Rate of Other Circulating Biomarkers (2018-2029)

      • 1.4.3 China Breast Cancer Liquid Biopsy Production Volume, Production Value and Growth Rate of Extracellular Vesicles (EVs) (2018-2029)

      • 1.4.4 China Breast Cancer Liquid Biopsy Production Volume, Production Value and Growth Rate of Cell-Free DNA (CfDNA) (2018-2029)

    • 1.5 China Breast Cancer Liquid Biopsy Market Analysis by Application from Consumption End

      • 1.5.1 China Breast Cancer Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.2 China Breast Cancer Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Laboratories (2018-2029)

      • 1.5.3 China Breast Cancer Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)

    • 1.6 China Breast Cancer Liquid Biopsy Market Analysis by Region

      • 1.6.1 North China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

    Chapter 2 China Breast Cancer Liquid Biopsy Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Breast Cancer Liquid Biopsy Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Breast Cancer Liquid Biopsy Market Status and Competition Analysis in 2023

      • 2.2.3 China Breast Cancer Liquid Biopsy Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Breast Cancer Liquid Biopsy Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Breast Cancer Liquid Biopsy Industry Development

    Chapter 3 Breast Cancer Liquid BiopsyIndustry Chain Analysis

    • 3.1 Breast Cancer Liquid Biopsy Industry Chain

    • 3.2 Breast Cancer Liquid Biopsy Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Breast Cancer Liquid Biopsy Market

    • 3.3 Breast Cancer Liquid Biopsy Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Breast Cancer Liquid Biopsy Market

    Chapter 4 China Breast Cancer Liquid Biopsy Market, by Type

    • 4.1 China Breast Cancer Liquid Biopsy Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Breast Cancer Liquid Biopsy Total Production Volume and Growth Rate from Production Side

    • 4.5 China Breast Cancer Liquid Biopsy Production Volume and Growth Rate, by Type

      • 4.5.1 China Breast Cancer Liquid Biopsy Production Volume and Growth Rate of Circulating Tumor Cells (CTCs)

      • 4.5.2 China Breast Cancer Liquid Biopsy Production Volume and Growth Rate of Other Circulating Biomarkers

      • 4.5.3 China Breast Cancer Liquid Biopsy Production Volume and Growth Rate of Extracellular Vesicles (EVs)

      • 4.5.4 China Breast Cancer Liquid Biopsy Production Volume and Growth Rate of Cell-Free DNA (CfDNA)

    Chapter 5 China Breast Cancer Liquid Biopsy Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Breast Cancer Liquid Biopsy Total Market Size and Growth Rate from Consumption End

    • 5.5 China Breast Cancer Liquid Biopsy Market Size and Growth Rate, by Application

      • 5.5.1 China Breast Cancer Liquid Biopsy Market Size and Growth Rate of Hospitals

      • 5.5.2 China Breast Cancer Liquid Biopsy Market Size and Growth Rate of Laboratories

      • 5.5.3 China Breast Cancer Liquid Biopsy Market Size and Growth Rate of Diagnostic Centers

    Chapter 6 China Breast Cancer Liquid Biopsy Market, by Region

    • 6.1 China Breast Cancer Liquid Biopsy Production Volume and Production Value, by Region

    • 6.2 China Breast Cancer Liquid Biopsy Sales Volume and Sales Value, by Region

    Chapter 7 North China Breast Cancer Liquid Biopsy Market Analysis

    • 7.1 North China Breast Cancer Liquid Biopsy Market, by Type

    • 7.2 North China Breast Cancer Liquid Biopsy Market, by Application

    Chapter 8 Central China Breast Cancer Liquid Biopsy Market Analysis

    • 8.1 Central China Breast Cancer Liquid Biopsy Market, by Type

    • 8.2 Central China Breast Cancer Liquid Biopsy Market, by Application

    Chapter 9 South China Breast Cancer Liquid Biopsy Market Analysis

    • 9.1 South China Breast Cancer Liquid Biopsy Market, by Type

    • 9.2 South China Breast Cancer Liquid Biopsy Market, by Application

    Chapter 10 East China Breast Cancer Liquid Biopsy Market Analysis

    • 10.1 East China Breast Cancer Liquid Biopsy Market, by Type

    • 10.2 East China Breast Cancer Liquid Biopsy Market, by Application

    Chapter 11 Northeast China Breast Cancer Liquid Biopsy Market Analysis

    • 11.1 Northeast China Breast Cancer Liquid Biopsy Market, by Type

    • 11.2 Northeast China Breast Cancer Liquid Biopsy Market, by Application

    Chapter 12 Southwest China Breast Cancer Liquid Biopsy Market Analysis

    • 12.1 Southwest China Breast Cancer Liquid Biopsy Market, by Type

    • 12.2 Southwest China Breast Cancer Liquid Biopsy Market, by Application

    Chapter 13 Northwest China Breast Cancer Liquid Biopsy Market Analysis

    • 13.1 Northwest China Breast Cancer Liquid Biopsy Market, by Type

    • 13.2 Northwest China Breast Cancer Liquid Biopsy Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Illumina

        • 14.1.1 Illumina Company Profile

        • 14.1.2 Illumina Breast Cancer Liquid Biopsy Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bio-Rad Laboratories

        • 14.2.1 Bio-Rad Laboratories Company Profile

        • 14.2.2 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 QIAGEN

        • 14.3.1 QIAGEN Company Profile

        • 14.3.2 QIAGEN Breast Cancer Liquid Biopsy Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Menarini Silicon Biosystems

        • 14.4.1 Menarini Silicon Biosystems Company Profile

        • 14.4.2 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Genomic Health

        • 14.5.1 Genomic Health Company Profile

        • 14.5.2 Genomic Health Breast Cancer Liquid Biopsy Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Biocept

        • 14.6.1 Biocept Company Profile

        • 14.6.2 Biocept Breast Cancer Liquid Biopsy Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Trovagene

        • 14.7.1 Trovagene Company Profile

        • 14.7.2 Trovagene Breast Cancer Liquid Biopsy Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Guardant Health

        • 14.8.1 Guardant Health Company Profile

        • 14.8.2 Guardant Health Breast Cancer Liquid Biopsy Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Myriad Genetics

        • 14.9.1 Myriad Genetics Company Profile

        • 14.9.2 Myriad Genetics Breast Cancer Liquid Biopsy Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 RainDance Technologies

        • 14.10.1 RainDance Technologies Company Profile

        • 14.10.2 RainDance Technologies Breast Cancer Liquid Biopsy Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Roche Diagnostics

        • 14.11.1 Roche Diagnostics Company Profile

        • 14.11.2 Roche Diagnostics Breast Cancer Liquid Biopsy Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Breast Cancer Liquid Biopsy Industry Research Conclusions

    • 15.2 Breast Cancer Liquid Biopsy Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Breast Cancer Liquid Biopsy Industry Market Size (2018-2029)

    • Figure China Breast Cancer Liquid Biopsy Production Volume, Production Value and Growth Rate of Circulating Tumor Cells (CTCs) (2018-2029)

    • Figure China Breast Cancer Liquid Biopsy Production Volume, Production Value and Growth Rate of Other Circulating Biomarkers (2018-2029)

    • Figure China Breast Cancer Liquid Biopsy Production Volume, Production Value and Growth Rate of Extracellular Vesicles (EVs) (2018-2029)

    • Figure China Breast Cancer Liquid Biopsy Production Volume, Production Value and Growth Rate of Cell-Free DNA (CfDNA) (2018-2029)

    • Figure China Breast Cancer Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Breast Cancer Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Laboratories (2018-2029)

    • Figure China Breast Cancer Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)

    • Figure North China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

    • Figure Central China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

    • Figure South China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

    • Figure East China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Breast Cancer Liquid Biopsy Market Size and Growth Rate from 2018-2029

    • Figure Breast Cancer Liquid Biopsy Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Breast Cancer Liquid Biopsy Market Share by Type in 2018

    • Figure China Breast Cancer Liquid Biopsy Market Share by Type in 2023

    • Figure China Breast Cancer Liquid Biopsy Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Breast Cancer Liquid Biopsy Production Volume and Growth Rate of Circulating Tumor Cells (CTCs) (2018-2023)

    • Figure China Breast Cancer Liquid Biopsy Production Volume and Growth Rate of Other Circulating Biomarkers (2018-2023)

    • Figure China Breast Cancer Liquid Biopsy Production Volume and Growth Rate of Extracellular Vesicles (EVs) (2018-2023)

    • Figure China Breast Cancer Liquid Biopsy Production Volume and Growth Rate of Cell-Free DNA (CfDNA) (2018-2023)

    • Figure China Breast Cancer Liquid Biopsy Market Share by Application in 2018

    • Figure China Breast Cancer Liquid Biopsy Market Share by Application in 2023

    • Figure China Breast Cancer Liquid Biopsy Total Market Size and Growth Rate from Consumption End

    • Figure China Breast Cancer Liquid Biopsy Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Breast Cancer Liquid Biopsy Market Size and Growth Rate of Laboratories (2018-2023)

    • Figure China Breast Cancer Liquid Biopsy Market Size and Growth Rate of Diagnostic Centers (2018-2023)

    • Table China Breast Cancer Liquid Biopsy Production Volume by Region (2018-2023)

    • Table China Breast Cancer Liquid Biopsy Production Volume Share by Region (2018-2023)

    • Figure China Breast Cancer Liquid Biopsy Production Volume Share by Region (2018-2023)

    • Table China Breast Cancer Liquid Biopsy Production Value by Region (2018-2023)

    • Table China Breast Cancer Liquid Biopsy Production Value Share by Region (2018-2023)

    • Figure China Breast Cancer Liquid Biopsy Production Value Share by Region (2018-2023)

    • Table China Breast Cancer Liquid Biopsy Sales Volume by Region (2018-2023)

    • Table China Breast Cancer Liquid Biopsy Sales Volume Share by Region (2018-2023)

    • Figure China Breast Cancer Liquid Biopsy Sales Volume Share by Region (2018-2023)

    • Table China Breast Cancer Liquid Biopsy Sales Value by Region (2018-2023)

    • Table China Breast Cancer Liquid Biopsy Sales Value Share by Region (2018-2023)

    • Figure China Breast Cancer Liquid Biopsy Sales Value Share by Region (2018-2023)

    • Table North China Breast Cancer Liquid Biopsy Production Volume by Type (2018-2023)

    • Table North China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Figure North China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Table North China Breast Cancer Liquid Biopsy Sales Volume by Application (2018-2023)

    • Table North China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Figure North China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Table Central China Breast Cancer Liquid Biopsy Production Volume by Type (2018-2023)

    • Table Central China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Figure Central China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Table Central China Breast Cancer Liquid Biopsy Sales Volume by Application (2018-2023)

    • Table Central China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Figure Central China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Table South China Breast Cancer Liquid Biopsy Production Volume by Type (2018-2023)

    • Table South China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Figure South China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Table South China Breast Cancer Liquid Biopsy Sales Volume by Application (2018-2023)

    • Table South China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Figure South China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Table East China Breast Cancer Liquid Biopsy Production Volume by Type (2018-2023)

    • Table East China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Figure East China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Table East China Breast Cancer Liquid Biopsy Sales Volume by Application (2018-2023)

    • Table East China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Figure East China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Table Northeast China Breast Cancer Liquid Biopsy Production Volume by Type (2018-2023)

    • Table Northeast China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Figure Northeast China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Table Northeast China Breast Cancer Liquid Biopsy Sales Volume by Application (2018-2023)

    • Table Northeast China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Table Southwest China Breast Cancer Liquid Biopsy Production Volume by Type (2018-2023)

    • Table Southwest China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Figure Southwest China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Table Southwest China Breast Cancer Liquid Biopsy Sales Volume by Application (2018-2023)

    • Table Southwest China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Table Northwest China Breast Cancer Liquid Biopsy Production Volume by Type (2018-2023)

    • Table Northwest China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Figure Northwest China Breast Cancer Liquid Biopsy Production Volume Share by Type (2018-2023)

    • Table Northwest China Breast Cancer Liquid Biopsy Sales Volume by Application (2018-2023)

    • Table Northwest China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Breast Cancer Liquid Biopsy Sales Volume Share by Application (2018-2023)

    • Table Illumina Company Profile

    • Table Illumina Breast Cancer Liquid Biopsy Revenue, Price and Gross (2018-2023)

    • Table Bio-Rad Laboratories Company Profile

    • Table Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue, Price and Gross (2018-2023)

    • Table QIAGEN Company Profile

    • Table QIAGEN Breast Cancer Liquid Biopsy Revenue, Price and Gross (2018-2023)

    • Table Menarini Silicon Biosystems Company Profile

    • Table Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue, Price and Gross (2018-2023)

    • Table Genomic Health Company Profile

    • Table Genomic Health Breast Cancer Liquid Biopsy Revenue, Price and Gross (2018-2023)

    • Table Biocept Company Profile

    • Table Biocept Breast Cancer Liquid Biopsy Revenue, Price and Gross (2018-2023)

    • Table Trovagene Company Profile

    • Table Trovagene Breast Cancer Liquid Biopsy Revenue, Price and Gross (2018-2023)

    • Table Guardant Health Company Profile

    • Table Guardant Health Breast Cancer Liquid Biopsy Revenue, Price and Gross (2018-2023)

    • Table Myriad Genetics Company Profile

    • Table Myriad Genetics Breast Cancer Liquid Biopsy Revenue, Price and Gross (2018-2023)

    • Table RainDance Technologies Company Profile

    • Table RainDance Technologies Breast Cancer Liquid Biopsy Revenue, Price and Gross (2018-2023)

    • Table Roche Diagnostics Company Profile

    • Table Roche Diagnostics Breast Cancer Liquid Biopsy Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US